NovaMed, Inc. investor files lawsuit against buyout

Jan. 31, 2011 - PRLog -- An investor in NovaMed shares filed a lawsuit in State Court in effort to block the proposed takeover of NovaMed, Inc. by People's Surgery Center Holdings, Inc. The plaintiff alleges the proposed $214 million merger with a unit of private equity firm H.I.G. Capital LLC significantly undervalues NovaMed.

If you purchased shares of NovaMed, Inc.  prior to the announcement and currently hold those NOVA shares, you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint the plaintiff alleges that the defendants breached their fiduciary duty arising out of their attempt to sell NovaMed to Surgery Center Holdings, Inc. via an unfair process at an unfair price.

On Friday, Jan. 21, 2011, NovaMed, Inc. announced that it has entered into a merger agreement to be acquired by an affiliate of Surgery Center Holdings, Inc. in a transaction valued at approximately $214 million, including the assumption or repayment of approximately $105 million of indebtedness. Surgery Partners is an affiliate of private equity investment firm H.I.G. Capital, LLC. Under the terms of the merger agreement, NovaMed, Inc. stockholders would receive $13.25 per NOVA share in cash. NovaMed said the offer represents a premium of 54.6% over the closing price of NovaMed's common stock as of the time of Surgery Partners' initial offer on August 2, 2010; a 17.7% premium over the Company's 90 day average closing price; and a 10.7% premium over the Company's 30 day average closing price.

But shares of NovaMed, Inc. traded in open market on Thursday as low as $12.72 and as high as $13.05 per share leaving NOVA investors with only a meager premium and even increased in response to the takeover news above to current offer to $13.31 per share during Fridays trading. Thus NOVA investors would exchange their shares at a discount and could have sold their shares in the open market at an offer exceeding price. In addition at least one analyst has set an $18.00 per share price target for NovaMed stock and NOVA shares traded during 2009 as high as $14.61 and on June 1 2010 had a split 1:3. During 2006 NOVA shares reached its 10year high over $25.71 per share. Additionally NovaMed has performed well for its shareholders in the past. NovaMed’s 12 months Total Revenue went from $104.26million in 2006 to $156.44million in 2009. Its Net Income went from $5.54million in 2006 to $7.51million in 2009. For the first three quarters in 2010 NovaMed, Inc. reported a combined nine months Total Revenue of $133.17million with a combined nine months Net Income of $5.15million. Further certain NovaMed directors and officers that in the aggregate own approximately 10.5% of NovaMed's outstanding shares have already entered into agreements with Surgery Partners to vote in favor of the merger.

Those who purchased shares of NovaMed, Inc. (Public, NASDAQ-NOVA) prior to the announcement and currently hold those NOVA shares , have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

# # #

The Shareholders Foundation, Inc. is an investor advocacy group. We do research related to shareholder issues and inform investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. At Shareholders Foundation, Inc. we are in contact with a large number of shareholders. We believe that together we can combine the interests of many investors, and use the size of our interest as leverage against the giant corporations. We offer help, support, and assistance for every shareholder. We help investors find answers to their questions and equitable solutions to their problems. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.